Quelle
American Diabetes Association, 75. Scientific Sessions, Boston, 5.–9. Juni 2015
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
DE Doch keine kardiovaskuläre Risikoerhöhung durch Sulfonylharnstoffe?. MMW - Fortschritte der Medizin 157, 32 (2015). https://doi.org/10.1007/s15006-015-3264-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-015-3264-2